Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikko Neuvonen

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Clinical Pharmacology and Therapeutics|December 24, 2002
Gemfibrozil greatly increases plasma concentrations of cerivastatinJanne T Backman, Carl Kyrklund, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|August 9, 2005
Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolitesJanne T Backman, Harri Luurila, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|July 23, 2024
Ticagrelor modestly raises plasma riboflavin concentration in humans and inhibits riboflavin transport by BCRP and MRP4Feng Deng, Kreetta Hämäläinen, Minna Lehtisalo, et al.
Clinical Pharmacology and Therapeutics|June 18, 2003
Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearanceCarl Kyrklund, Janne T Backman, Mikko Neuvonen, et al.
British Journal of Clinical Pharmacology|January 30, 2004
Effect of rifampicin on pravastatin pharmacokinetics in healthy subjectsCarl Kyrklund, Janne T Backman, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|May 19, 2005
Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazoneTiina Jaakkola, Janne T Backman, Mikko Neuvonen, et al.
Pharmacogenetics and Genomics|November 17, 2006
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acidMarja K Pasanen, Mikko Neuvonen, Pertti J Neuvonen, et al.
Clinical Pharmacology and Therapeutics|January 30, 2004
Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppressionMia Hedman, Pertti J Neuvonen, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|December 14, 2004
Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolismMarika T Granfors, Janne T Backman, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|September 28, 2021
Performance of Plasma Coproporphyrin I and III as OATP1B1 Biomarkers in HumansMikko Neuvonen, Aleksi Tornio, Päivi Hirvensalo, et al.
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Clinical Pharmacology and Therapeutics|December 24, 2002
Gemfibrozil greatly increases plasma concentrations of cerivastatinJanne T Backman, Carl Kyrklund, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|August 9, 2005
Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolitesJanne T Backman, Harri Luurila, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|July 23, 2024
Ticagrelor modestly raises plasma riboflavin concentration in humans and inhibits riboflavin transport by BCRP and MRP4Feng Deng, Kreetta Hämäläinen, Minna Lehtisalo, et al.
Clinical Pharmacology and Therapeutics|June 18, 2003
Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearanceCarl Kyrklund, Janne T Backman, Mikko Neuvonen, et al.
British Journal of Clinical Pharmacology|January 30, 2004
Effect of rifampicin on pravastatin pharmacokinetics in healthy subjectsCarl Kyrklund, Janne T Backman, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|May 19, 2005
Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazoneTiina Jaakkola, Janne T Backman, Mikko Neuvonen, et al.
Pharmacogenetics and Genomics|November 17, 2006
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acidMarja K Pasanen, Mikko Neuvonen, Pertti J Neuvonen, et al.
Clinical Pharmacology and Therapeutics|January 30, 2004
Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppressionMia Hedman, Pertti J Neuvonen, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|December 14, 2004
Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolismMarika T Granfors, Janne T Backman, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|September 28, 2021
Performance of Plasma Coproporphyrin I and III as OATP1B1 Biomarkers in HumansMikko Neuvonen, Aleksi Tornio, Päivi Hirvensalo, et al.
Pageof 11